Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1 - PubMed (original) (raw)

Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1

F d'Adda di Fagagna et al. J Virol. 1995 May.

Abstract

The human transcription factor USF, purified from HeLa cells, and its recombinant 43-kDa component bind to the long terminal repeat (LTR) of human immunodeficiency virus type 1. The proteins footprint over nucleotides from position -173 to -157 upstream of the transcription start site, generating strong DNAse I hypersensitivity sites at the 3' sides on both strands. As detected by methylation protection studies, the factor forms symmetric contacts with the guanines of the palindromic CACGTG core of the recognized sequence. Its binding ability is abolished by the mutation of this core sequence and is strongly reduced by the cytosine methylation of the central CpG dinucleotide. Upon binding, both recombinant and purified USFs bend the LTR DNA template. The role of USF in the control of transcription initiation from the LTR was tested by in vitro transcription assays. Upon addition of the protein, transcription from constructs containing an intact binding site is increased, while the responsiveness in constructs with a mutated sequence is abolished. Furthermore, the addition of a decoy plasmid which contains multiple repeats of the target sequence results in downregulation of transcription from the LTR. These results suggest that USF is a positive regulator of LTR-mediated transcriptional activation.

PubMed Disclaimer

Cited by

The E3 Ubiquitin-Protein Ligase Cullin 3 Regulates HIV-1 Transcription.
Langer S, Yin X, Diaz A, Portillo AJ, Gordon DE, Rogers UH, Marlett JM, Krogan NJ, Young JAT, Pache L, Chanda SK. Langer S, et al. Cells. 2020 Sep 1;9(9):2010. doi: 10.3390/cells9092010. Cells. 2020. PMID: 32882949 Free PMC article.
Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements.
Pöhlmann S, Flöss S, Ilyinskii PO, Stamminger T, Kirchhoff F. Pöhlmann S, et al. J Virol. 1998 Jul;72(7):5589-98. doi: 10.1128/JVI.72.7.5589-5598.1998. J Virol. 1998. PMID: 9621017 Free PMC article.
Upstream Stimulatory Factors Regulate HIV-1 Latency and Are Required for Robust T Cell Activation.
Horvath RM, Sadowski I. Horvath RM, et al. Viruses. 2023 Jun 28;15(7):1470. doi: 10.3390/v15071470. Viruses. 2023. PMID: 37515158 Free PMC article.
Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.
Shah S, Nonnemacher MR, Pirrone V, Wigdahl B. Shah S, et al. J Neuroimmune Pharmacol. 2010 Sep;5(3):278-93. doi: 10.1007/s11481-010-9207-x. Epub 2010 Apr 13. J Neuroimmune Pharmacol. 2010. PMID: 20387125 Free PMC article. Review.
In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice.
Kurth J, Buzy JM, Lindstrom L, Clements JE. Kurth J, et al. J Virol. 1996 Nov;70(11):7686-94. doi: 10.1128/JVI.70.11.7686-7694.1996. J Virol. 1996. PMID: 8892889 Free PMC article.

References

1. EMBO J. 1994 Jan 1;13(1):180-9 - PubMed
1. Mol Cell Biol. 1994 Mar;14(3):1582-93 - PubMed
1. Nature. 1994 Jan 20;367(6460):295-9 - PubMed
1. Nucleic Acids Res. 1994 Feb 11;22(3):427-33 - PubMed
1. J Virol. 1994 May;68(5):3163-74 - PubMed

Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1 - PubMed (original) (raw)